Prognostic factors in non-metastatic HER2 ‘low’ and HER2 ‘negative’ breast cancer: single institute experience

2024/01/05 by Alper Türkel, Mutlu Doğan, Elif Sertesen +3
Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Breast Cancer Therapies #Breast Cancer Treatment Studies #Breast cancer #Cancer #HER2 negative #HER2/EGFR in Cancer Research #Internal medicine #Medicine #Metastatic breast cancer #Oncology

paper · doi:10.1007/s00508-023-02315-z

published in Wiener klinische Wochenschrift 136(11-12), 340-346 (Springer Science+Business Media)

openalex publication_date 2024/01/05 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/06

Citations

• Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
• Breast cancer statistics, 2019